KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Capital Employed (2016 - 2025)

Sarepta Therapeutics has reported Return on Capital Employed over the past 15 years, most recently at 0.3% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.3% for Q4 2025, down 37.0% from a year ago — trailing twelve months through Dec 2025 was 0.3% (down 37.0% YoY), and the annual figure for FY2025 was 0.27%, down 35.0%.
  • Return on Capital Employed for Q4 2025 was 0.3% at Sarepta Therapeutics, down from 0.05% in the prior quarter.
  • Over the last five years, Return on Capital Employed for SRPT hit a ceiling of 0.07% in Q4 2024 and a floor of 0.3% in Q4 2025.
  • Median Return on Capital Employed over the past 5 years was 0.16% (2022), compared with a mean of 0.13%.
  • Biggest five-year swings in Return on Capital Employed: rose 21bps in 2024 and later crashed -37bps in 2025.
  • Sarepta Therapeutics' Return on Capital Employed stood at 0.19% in 2021, then dropped by -13bps to 0.21% in 2022, then surged by 50bps to 0.11% in 2023, then soared by 168bps to 0.07% in 2024, then crashed by -521bps to 0.3% in 2025.
  • The last three reported values for Return on Capital Employed were 0.3% (Q4 2025), 0.05% (Q3 2025), and 0.0% (Q2 2025) per Business Quant data.